Theranostics Health Inc. to Present at Biotech Showcase™ 2015
Rockville, MD, January 7, 2015 – Theranostics Health Inc. announced today that Luis Gutierrez,
President and CEO, will be presenting at the Biotech Showcase™ 2015 Conference being held in San
Francisco, CA. Having been angel-supported to this point, this presentation marks the kick-off of the
company’s first round of seeking institutional and strategic investors.
Details of Theranostics Health’s presentation are as follows:
Event:
Date:
Time:
Location:
Biotech Showcase™ 2015 Conference
Monday, January 12
11:15 am
Room Hearst: Parc 55 Wyndham San Francisco Union Square Hotel
Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech Showcase is an investor and
partnering conference devoted to providing private and public biotechnology and life sciences
companies an opportunity to present to, and meet with, investors and pharmaceutical executives during
the course of one of the industry’s largest annual healthcare investor conferences. Now in its seventh
year, Biotech Showcase is expected to attract upwards of 1,500 attendees.
About Theranostics Health Inc.
Theranostics Health, a privately-held biotechnology company, develops technologies to measure the
activation status of key signaling pathways that are instrumental in the development and progression of
cancers and for which there are therapies without guiding tests. The Company has a successful 7-year
track record of providing translational research services to pharmaceutical and biotechnology drug
development companies. Having achieved CAP/CLIA certification in late 2013, Theranostics Health is
now offering to medical oncologists proteomic-based molecular diagnostic tests through its TheraLink®
HER Family Assay, and has a number of additional tests in development.
About Demy-Colton Life Science Advisors
Demy-Colton Life Science Advisors is focused exclusively on facilitating the growth of the life science
industry. Now going into its fifth year, Demy-Colton has developed a number of high-value added
conferences to address the business and development needs of the biotechnology industry; it provides
partnering services and it has helped launch a unique investor website and newsletter. For more
information please visit www.demy-colton.com.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma
and medical device companies have leveraged EBD Group's partnering conferences, technology and
services to identify business opportunities and develop strategic relationships essential to their success.
For more information please visit www.ebdgroup.com or follow EBD Group on Twitter at
twitter.com/ebdgroup.
Contacts:
For Theranostics Health Inc.
For Biotech Showcase™ 2015
Luis T. Gutierrez, Jr.
President & Chief Executive Officer
Lawrence Joseph
Demy-Colton Life Sciences Advisors
15010 Broschart Road, Suite 200
Rockville, MD 20850
Office: +1-301-251-4443 Ext. 116
LGutierrez@TheranosticsHealth.com
www.TheranosticsHealth.com
+1-646-895-0981
ljoseph@demy-colton.com
Christina Kirsch
EBD Group
+1-760-692-5906
ckirsch@ebdgroup.com